UCL Cancer Institute
London, United Kingdom
After qualifying in medicine and surgery in 1986, Professor Bridgewater specialised in medical oncology at the Middlesex, Mount Vernon and Royal Marsden Hospitals. He undertook a PhD in gene therapy at the Institute of Cancer Research, and subsequently took a senior lecturer position in medical oncology at UCL in 1999.
Professor Bridgewater led the National Cancer Research Institute (NCRI) Study Group in upper gastrointestinal malignancy and has contributed to landmark studies in gastrointestinal (GI) malignancy. He has led a series of biliary tract cancer and colorectal studies that have defined management in the adjuvant and advanced settings. He leads the Genomics England UGI theme, incorporating genomics into standard of care and research agendas.
Professor Bridgewater has served on several research and funding committees including the Clinical Trials Advisory and Awards Committee, ASCO, INSERM, INCa and National Institute for Health and Care Excellence committees.
Wednesday, June 28, 2023
18:35 – 18:45 CEST
Wednesday, June 28, 2023
18:45 – 18:55 CEST